199 related articles for article (PubMed ID: 18328174)
1. No evidence-based practice by biased information from systematic reviews: the case of etanercept and infliximab for the treatment of psoriatic arthritis.
Corrao S; Puleo A; Pistone G; Calvo L; Scaglione R; Licata G
Clin Exp Rheumatol; 2008; 26(1):164; author reply 165. PubMed ID: 18328174
[No Abstract] [Full Text] [Related]
2. Psoriatic arthritis patients doing better on infliximab than etanercept.
Smith N; Gadsby K; Deighton C
Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216
[No Abstract] [Full Text] [Related]
3. TNFalpha inhibition in psoriatic arthritis: cause for hope.
Zabraniecki L; Fournié B
Joint Bone Spine; 2001 Mar; 68(2):106-8. PubMed ID: 11324924
[No Abstract] [Full Text] [Related]
4. Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator.
Migliore A; Bizzi E; Broccoli S; Laganà B
Clin Rheumatol; 2012 Jan; 31(1):193-4. PubMed ID: 22005889
[No Abstract] [Full Text] [Related]
5. Infliximab treatment in psoriatic arthritis: our experience.
Rioda WT; Adorni G
Acta Biomed; 2006 Aug; 77(2):95-102. PubMed ID: 17172189
[TBL] [Abstract][Full Text] [Related]
6. [Biological agents in treatment of psoriatic arthritis].
Lewicki M; Dutkiewicz B; Widuchowska M; Kucharz EJ
Pol Merkur Lekarski; 2008 Jul; 25(145):97-100. PubMed ID: 18839626
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of psoriatic arthritis with TNF alpha-antagonists].
Antoni C; Manger B
Z Rheumatol; 2003 Jun; 62(3):235-9. PubMed ID: 12827399
[TBL] [Abstract][Full Text] [Related]
8. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review.
Woolacott NF; Khadjesari ZC; Bruce IN; Riemsma RP
Clin Exp Rheumatol; 2006; 24(5):587-93. PubMed ID: 17181932
[TBL] [Abstract][Full Text] [Related]
9. Patient profiles in psoriatic disease: a case-based approach.
Wiatrowski M; Furfaro N
Dermatol Nurs; 2007 Oct; Suppl():5-19; quiz 20-1. PubMed ID: 18341241
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.
Mease PJ
Ann Rheum Dis; 2002 Apr; 61(4):298-304. PubMed ID: 11874829
[TBL] [Abstract][Full Text] [Related]
11. Errors noted in: re: Migliore A, Bizzi E, Broccoli S Laganà (2011). Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator. Published on line June 21st 2011.
O'Regan C
Clin Rheumatol; 2011 Dec; 30(12):1647-8. PubMed ID: 21938451
[No Abstract] [Full Text] [Related]
12. Biologic therapy of psoriatic arthritis.
Gladman DD
Reumatismo; 2007; 59 Suppl 1():85-7. PubMed ID: 17828353
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
Jobanputra P; Barton P; Bryan S; Burls A
Health Technol Assess; 2002; 6(21):1-110. PubMed ID: 12387732
[No Abstract] [Full Text] [Related]
14. Newly available treatments for psoriatic arthritis and their impact on skin psoriasis.
Galadari H; Fuchs B; Lebwohl M
Int J Dermatol; 2003 Mar; 42(3):231-7. PubMed ID: 12653923
[TBL] [Abstract][Full Text] [Related]
15. Psoriatic arthritis: a guide for dermatology nurses.
Gottlieb AB
Dermatol Nurs; 2003 Apr; 15(2):107-10, 113-8; quiz 119. PubMed ID: 12751345
[TBL] [Abstract][Full Text] [Related]
16. Psoriatic arthritis.
Goupille P
Joint Bone Spine; 2005 Dec; 72(6):466-70. PubMed ID: 16310398
[TBL] [Abstract][Full Text] [Related]
17. Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis.
Kirson NY; Rao S; Birnbaum HG; Kantor E; Wei RS; Cifaldi M
J Med Econ; 2013; 16(4):479-89. PubMed ID: 23339434
[TBL] [Abstract][Full Text] [Related]
18. Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis.
Fénix-Caballero S; Alegre-del Rey EJ; Castaño-Lara R; Puigventós-Latorre F; Borrero-Rubio JM; López-Vallejo JF
J Clin Pharm Ther; 2013 Aug; 38(4):286-93. PubMed ID: 23590560
[TBL] [Abstract][Full Text] [Related]
19. Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator.
Migliore A; Bizzi E; Broccoli S; Laganà B
Clin Rheumatol; 2012 Jan; 31(1):133-7. PubMed ID: 21701796
[TBL] [Abstract][Full Text] [Related]
20. TNFalpha therapy in psoriatic arthritis and psoriasis.
Mease P
Ann Rheum Dis; 2004 Jul; 63(7):755-8. PubMed ID: 15194567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
